Direkt zum Inhalt
  • Paul Scherrer Institut PSI
  • PSI Research, Labs & User Services

Digital User Office

  • Digital User Office
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI)
Suche
Paul Scherrer Institut (PSI)

Hauptnavigation

  • Research at PSIÖffnen dieses Hauptmenu Punktes
    • Research Initiatives
    • Ethics and Research integrity
    • Scientific Highlights
    • Scientific Events
    • Scientific Career
    • PSI-FELLOW
    • PSI Data Policy
  • Research Divisions and LabsÖffnen dieses Hauptmenu Punktes
    • Overview
    • Research with Neutrons and Muons
    • Photon Science
    • Energy and Environment
    • Nuclear Energy and Safety
    • Biology and Chemistry
    • Scientific Computing, Theory and Data
    • Large Research Facilities
  • Facilities and InstrumentsÖffnen dieses Hauptmenu Punktes
    • Overview
    • Large Research Facilities
    • Facilities
    • PSI Facility Newsletter
  • PSI User ServicesÖffnen dieses Hauptmenu Punktes
    • User Office
    • Methods at the PSI User Facilities
    • Proposals for beam time
    • Proposal Deadlines
    • Data Analysis Service (PSD)
    • EU support programmes
  • New ProjectsÖffnen dieses Hauptmenu Punktes
    • SLS 2.0
    • IMPACT
  • DE
  • EN
  • FR

Digital User Office (mobile)

  • Digital User Office

Sie befinden sich hier:

  1. PSI Home
  2. Labs & User Services
  3. BIO
  4. Center for Radiopharmaceutical Sciences (CRS)

Sekundäre Navigation

Center for Radiopharmaceutical Sciences (CRS)

  • Laboratory Head
  • Project Leader
  • Scientific Highlights
  • Groups
    • Nuclide Chemistry
    • Pharmacology
    • Clinical Drug Supply
    • Radionuclide-Production and Maintenance
    • Radionuclide Development
  • Facilities and Instruments
  • Teaching and Education
  • Publications
  • Team / Contact
  • News & Events

Info message

Dieser Inhalt ist nicht auf Deutsch verfügbar.

Center for Radiopharmaceutical Sciences (CRS)

The Center for Radiopharmaceutical Sciences (CRS), headed by Prof. Dr. Roger Schibli, is a joint endeavor between the Paul Scherrer Institute and the ETH Zurich. CRS is working towards clinical application of radiopharmaceuticals based on an interdisciplinary approach involving radiochemistry, radiopharmaceutical chemistry, biochemistry, molecular biology, pharmacy and pharmacology.

CRS offer the entire spectrum of radiopharmaceutical sciences which includes radionuclide devlopment (in close cooperation with the Laboratory of Radiochemistry at PSI), radiolabeling chemistry, lead-optimization, in vitro and in vivo assessment, pre-clinical nuclear imaging (PET and SPECT) and radionuclide therapy as well as translation of new and novel radiotracers for clinical studies (in collaboration with academic and industrial partners).

Hiking day one

Mit Sidebar

Contact

Prof. Dr. Roger Schibli
Center for Radiopharmaceutical Sciences
Paul Scherrer Institut
OIPA/103
5232 Villigen PSI
Switzerland

Telephone Office: +41 56 310 28 43
E-mail Office: sandha.keller@psi.ch

Contact

ETH
Prof. Dr. Roger Schibli
Swiss Federal Institute of Technology Zurich
Radiopharmaceutical Sciences
ETH Zurich

Contact

University Hospital Zurich
Radiopharmacy
USZ

Anfahrt zum PSI

Wie Sie uns finden (Beschreibung und Karte)

top

Fussbereich

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Schweiz

Telefon: +41 56 310 21 11
Telefax: +41 56 310 21 99

Der Weg zu uns
Kontakt

Besucherzentrum psi forum
Schülerlabor iLab
Zentrum für Protonentherapie
PSI Bildungszentrum
PSI Guest House (in english)
PSI Gastronomie
psi forum-Shop

 

Service & Support

  • Telefonbuch
  • User Office
  • Accelerator Status
  • Publikationen des PSI
  • Lieferanten
  • E-Rechnung
  • Computing
  • Sicherheit

Karriere

  • Arbeiten am PSI
  • Stellenangebote
  • Aus- und Weiterbildung
  • Career Center
  • Berufsbildung
  • PSI Bildungszentrum

Für die Medien

  • Das PSI in Kürze
  • Zahlen und Fakten
  • Mediacorner
  • Medienmitteilungen
  • Social Media

Folgen Sie uns: Twitter (deutsch) LinkedIn Youtube Facebook Instagram Issuu RSS

Footer legal

  • Impressum
  • Nutzungsbedingungen
  • Editoren-Login